Antibody‐mediated targeting of the CSF1‐CSF1R axis and depletion of macrophages through pharmacological CSF1 inhibition demonstrated reduced tumor progression and increased chemosensitivity in several mouse models of cancer.162, 163, 164. The gene discussed is CSF1; the disease is cancer.